Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (1)
P 1 (1)
P 2 (3)
P 4 (1)

Trial Status

Recruiting4
Not Yet Recruiting1
Active Not Recruiting1
Enrolling By Invitation1

Clinical Trials (7)

Showing 7 of 7 trials
NCT04862221Phase 2Active Not Recruiting

TReatment for ImmUne Mediated PathopHysiology

NCT07660783Phase 2Not Yet Recruiting

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

NCT07652580Recruiting

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

NCT07221565Phase 1Enrolling By Invitation

Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

NCT07284641Phase 2Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

NCT06829238Phase 4Recruiting

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

NCT07384897Not ApplicableRecruiting

Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease

Showing all 7 trials

Research Network

Activity Timeline